Can-Fite Biopharma Ltd Sponsored ADR (Israel) (CANF)

1.27 -0.02 (-1.55%)

IEX Real-Time Price

July 20, 2018 EST.

NYSE American : Healthcare

Prev Close 1.29

Price Open 1.28

Volume: 70,892

Avg Volume: 419,546

Market Cap: 25.38M

P/E Ratio -3.97

52 Wk Range 1.12-2.75



CANF Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-06-29
19.98M
302,241
0.57
1.51%

2018-06-15
19.98M
351,936
0.72
1.76%

2018-05-31
19.98M
117,270
1.90
0.59%

2018-05-15
19.98M
112,229
3.37
0.56%




CANF Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-06-01
Q1 2018
N/A
-0.08 (1)
-0.10
-0.02

2018-05-29
Q1 2018
N/A
-0.08 (1)
0.00
0.00

2018-03-30
Q4 2017
N/A
-0.14 (2)
0.00
0.00

2018-03-23
Q4 2017
N/A
-0.15 (2)
-0.06
0.09

News

Can-Fite granted Australian and Chinese patents for erectile dysfunction drug, shares up 5.7% premarket (2018-07-17 07:39 SeekingAlpha)

Australian and Chinese patent offices have granted Can-Fite BioPharma (NYSEMKT: CANF ) a patent for the utilization of A3 adenosine receptor ligands in the treatment of sexual dysfunction, in a patent titled, "A3 adenosine receptor ligands for use in treatment of a sexual dysfunction." M…

 

Can-Fite Granted Australian and Chinese Patents for Erectile Dysfunction Drug (2018-07-17 07:00 Business Wire)

Erectile dysfunction market is estimated to reach $3.2 billion by 2022 Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address liver diseases, inflammatory diseases and sexual dysfunctio…

 


Statistics

Shares Outstanding: 19.98M

Top 15 Institution Percent: 5.70

Price To Sales: 19.47

Price To Book: 3.47

Revenue: 664653

Gross Profit: N/A

Cash: 11.97M

Debt: N/A

Return On Assets: -40.20

Return On Equity: -75.14

Profit Margin: N/A

Price History

Beta: 2.08

50-day Moving Avg: 1.27

200-day Moving Avg: 1.54

YTD Change: -20.87

5-day Change: 4.96

1-month Change: -0.78

3-month Change: -7.30

6-month Change: -29.83

1-year Change: -29.34

Revenue Per Share: 0.00

Revenue Per Employee: 94950.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Exchange: NYSE American

Industry: Biotechnology

Sector: Healthcare

Website: http://www.canfite.com

Can Fite Biofarma Ltd is a clinical stage biopharmaceutical company. It develops orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases.